Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 217

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation

Open access
Manta, Stella, Dong, Jianming, Debonnel, Guy, Blier, Pierre · 2009 · Journal of Psychiatry and Neuroscience

Abstract

Background: Vagus nerve stimulation (VNS) is a recent intervention for treatment-resistant depression. Electrophysiological recordings in the rat brain showed that VNS increases the firing rate of norepinephrine (NE) neurons after 1 day of stimulation and that of serotonin (5-HT) neurons after 14 days. This study was conducted to further characterize these effects. Methods: We implanted rats with a VNS electrode and stimulator. We used the selective noradrenergic toxin DSP-4 to lesion NE neurons of the locus coeruleus. We recorded dorsal raphe 5-HT neurons under chloral hydrate anesthesia. We recorded hippocampus CA 3 pyramidal neurons using 5-barreled iontophoretic pipettes. Results: Analysis of a previously published data set revealed that VNS increased not only the spontaneous firing rates of NE neurons, but also the percentage of neurons firing in bursts. The enhancement of the 5-HT neuron firing rate by VNS was abolished by lesioning NE neurons. We found that VNS increased the degree of activation of postsynaptic α 1-adrenoceptors on 5-HT neurons, probably through an increased release of endogenous NE. The tonic activation of postsynaptic 5-HT 1A receptors in the hippocampus was enhanced after 14 days of VNS, as with other antidepressant treatments. Limitations: Our study limitations include the fact that we turned off the stimulator during the electrophysiological recordings, which likely decreased the vagal tone to the brain. Also, we obtained the data while the animals were under anesthesia, therefore studies need to be carried out in unanesthetized rats to ascertain whether the anesthetic agent influenced the changes observed between control rats and those treated with VNS. Conclusion: Vagus nerve stimulation initially increases the firing activity and pattern of NE neurons and subsequently those of 5-HT neurons, presumably as a cascade effect via α 1-postsynaptic adrenoceptors. To date, VNS appears to be a unique antidepressant treatment increasing 5-HT transmission and enhancing the firing activity of NE neurons. These effects could contribute to the effectiveness of VNS in treatment-resistant depression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1139/jpn.0936

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 44

  1. Foley JO, 1937, J Comp Neurol, 67, 49, 10.1002/cne.900670104 · DOI · Paper page
  2. Buoni S, 2004, Brain Dev, 26, 158, 10.1016/S0387-7604(03)00120-7 · DOI
  3. Elger G, 2000, Epilepsy Res, 42, 203, 10.1016/S0920-1211(00)00181-9 · DOI · Paper page
  4. Schachter SC, 2004, Epilepsy Behav, 5, S56, 10.1016/j.yebeh.2003.11.007 · DOI
  5. Sackeim HA, 2001, Neuropsychopharmacology, 25, 713, 10.1016/S0893-133X(01)00271-8 · DOI · Paper page
  6. Marangell LB, 2002, Biol Psychiatry, 51, 280, 10.1016/S0006-3223(01)01343-9 · DOI · Paper page
  7. Krahl SE, 2004, J Psychiatr Res, 38, 237, 10.1016/j.jpsychires.2003.11.005 · DOI
  8. Daban C, 2008, J Affect Disord, 110, 1, 10.1016/j.jad.2008.02.012 · DOI · Paper page
  9. Pineyro G, 1999, Pharmacol Rev, 51, 533, 10.1016/S0031-6997(24)01417-0 · DOI · Paper page
  10. Blier P, 1994, Trends Pharmacol Sci, 15, 220, 10.1016/0165-6147(94)90315-8 · DOI · Paper page
  11. Haddjeri N, 1998, J Neurosci, 18, 10150, 10.1523/JNEUROSCI.18-23-10150.1998 · DOI · Paper page
  12. Svensson TH, 1975, Brain Res, 92, 291, 10.1016/0006-8993(75)90276-0 · DOI · Paper page
  13. Curet O, 1989, Brain Res, 499, 18, 10.1016/0006-8993(89)91131-1 · DOI
  14. Schoffelmeer AN, 1983, Naunyn Schmiedebergs Arch Pharmacol, 323, 188, 10.1007/BF00497661 · DOI
  15. Crews FT, 1978, Science, 202, 322, 10.1126/science.211589 · DOI · Paper page
  16. McMillen BA, 1980, Eur J Pharmacol, 61, 239, 10.1016/0014-2999(80)90126-0 · DOI · Paper page
  17. Vandermaelen CP, 1983, Brain Res, 289, 109, 10.1016/0006-8993(83)90011-2 · DOI · Paper page
  18. Millan MJ, 1994, J Pharmacol Exp Ther, 269, 121, 10.1016/S0022-3565(25)38665-9 · DOI
  19. Dorr AE, 2006, J Pharmacol Exp Ther, 318, 890, 10.1124/jpet.106.104166 · DOI · Paper page
  20. Grzanna R, 1989, J Histochem Cytochem, 37, 1435, 10.1177/37.9.2768812 · DOI
  21. Logue MP, 1985, Life Sci, 37, 403, 10.1016/0024-3205(85)90401-1 · DOI
  22. Aghajanian GK, 1982, J Neurosci, 2, 1786, 10.1523/JNEUROSCI.02-12-01786.1982 · DOI · Paper page
  23. Grace AA, 1984, J Neurosci, 4, 2877, 10.1523/JNEUROSCI.04-11-02877.1984 · DOI · Paper page
  24. Hajos M, 1995, Neuroscience, 69, 189, 10.1016/0306-4522(95)00227-A · DOI
  25. Kandel ER, 1961, J Neurophysiol, 24, 243, 10.1152/jn.1961.24.3.243 · DOI · Paper page
  26. Ranck JB, 1973, Exp Neurol, 41, 461, 10.1016/0014-4886(73)90290-2 · DOI · Paper page
  27. Florin-Lechner SM, 1996, Brain Res, 742, 89, 10.1016/S0006-8993(96)00967-5 · DOI · Paper page
  28. Ghanbari R, 2008, J Psychopharmacol
  29. Follesa P, 2007, Brain Res, 1179, 28, 10.1016/j.brainres.2007.08.045 · DOI · Paper page
  30. Roosevelt RW, 2006, Brain Res, 1119, 124, 10.1016/j.brainres.2006.08.048 · DOI · Paper page
  31. Gobbi G, 2007, Eur Neuropsychopharmacol, 17, 328, 10.1016/j.euroneuro.2006.07.004 · DOI
  32. Henry TR, 2002, Neurology, 59, S3
  33. Van Bockstaele EJ, 1999, J Comp Neurol, 412, 410, 10.1002/(SICI)1096-9861(19990927)412:3<410::AID-CNE3>3.0.CO;2-F · DOI · Paper page
  34. Ennis M, 1988, J Neurosci, 8, 3644, 10.1523/JNEUROSCI.08-10-03644.1988 · DOI · Paper page
  35. Ennis M, 1989, J Neurosci, 9, 2973, 10.1523/JNEUROSCI.09-08-02973.1989 · DOI · Paper page
  36. Cunningham JT, 2008, Neuropsychopharmacology, 33, 1884, 10.1038/sj.npp.1301570 · DOI · Paper page
  37. Bosker F, 1994, J Neurochem, 63, 2165, 10.1046/j.1471-4159.1994.63062165.x · DOI
  38. Hery F, 1986, Ann N Y Acad Sci, 473, 239, 10.1111/j.1749-6632.1986.tb23620.x · DOI
  39. Baraban JM, 1980, Neuropharmacology, 19, 355, 10.1016/0028-3908(80)90187-2 · DOI · Paper page
  40. Kasamo K, 2001, Neuropsychopharmacology, 24, 141, 10.1016/S0893-133X(00)00181-0 · doi:10.1016/s0893-133x(00)00181-0
  41. Besson A, 2000, Eur Neuropsychopharmacol, 10, 177, 10.1016/S0924-977X(00)00069-9 · DOI
  42. Szabo ST, 2001, Neuropsychopharmacology, 25, 845, 10.1016/S0893-133X(01)00284-6 · DOI
  43. Trulson ME, 1979, Brain Res, 163, 135, 10.1016/0006-8993(79)90157-4 · DOI · Paper page
  44. Haddjeri N, 2008, Eur J Pharmacol, 600, 64, 10.1016/j.ejphar.2008.10.001 · DOI

Cited by

See all 217

Metadata

Authors
Manta, S., Dong, J., Debonnel, G., & Blier, P.
Venue
Journal of Psychiatry and Neuroscience
Published
2009-07
Volume
34
Issue
4
Pages
272-280
ISSN
  • 1180-4882 (ISSN-L)
  • 1488-2434
OpenAlex
W4413981339
Cited by
217
References
5
FWCI
5.77
Type
journal article
Language
en
Open access
green
Licence
www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.